N,N-Dimethyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrimidin-2-amine, 95.0%, 5g

acteoside, with analyt. Documents, 20 mg, glass packaging

(1R,2R)-2-((R)-1-phenylethylamino)cyclohexanol, 98%, 5g

tert-Butyl but-3-enoate, 95%, 25g

1,5-Naphthalenebis(trifluoromethanesulfonate)>98.0%(GC)1g

MOXIFLOXACIN, 95%, 5g

8-methoxy-3,4-dihydroquinazolin-4-one, 97%, 10g

tert-Butyl 1-amino-3-azabicyclo[3.2.0]heptane-3-carboxylate, 97%, 500mg

1/? first red plate 530 nm in slide for transmitted illumination of iScope models for polarization

alpha-D-Mannose pentaacetate, 98.0%, 500g

tert-Butyl 3-(2-Aminoethoxy)propanoate>95.0%(GC)250mg

(S)-3,3'-Bis(perfluorophenyl)-[1,1'-binaphthalene]-2,2'-diol, 97%, 1g

Bowl stainless steel, 5.6 l, 1 Piece